Melinta Therapeutics

KIMYRSA

View Prices
  1. Home
    2.  / 
  2. J Code
    3.  / KIMYRSA – J2406

Manufacturer:

Melinta Therapeutics

Name:

KIMYRSA

HCPCS Code Descriptor:

Injection, oritavancin (kimyrsa), 10 mg

Category:

J Code

HCPCS:

J2406

NDC(s):

70842-0225-01

Primary Type:

Antibiotic

Generic Status:

Single-Source

Route of Administration:

Intravenous

About:

KIMYRSA is an Antibiotic drug manufactured by Melinta Therapeutics and administered via the Intravenous route of administration. The J Code: J2406 is aligned to the drug KIMYRSA.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

10/1/21

HCPCS Effective Date:

10/1/21

HCPCS Short Description:

Injection, oritavancin 10 mg

Billing and Coding Guide:

https://kimyrsa.com/wp-content/uploads/2022/04/PP-KIM-US-0148-KIMYRSA-2022-Billing-and-Coding-Guide.pdf

Patient Assistance:

https://kimyrsa.com/support-programs/